A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.
AMA J Ethics. 2021;23(9):E712-720. doi:
10.1001/amajethics.2021.712.
A gynecologic oncology ethics education program intended to engage students and foster open exchange was designed after review of ethics consults at a tertiary cancer center over a 15-year period.
AMA J Ethics. 2015;17(9):834-838. doi:
10.1001/journalofethics.2015.17.9.medu1-1509.
Professor Katie Watson joins Ethics Talk to consider key questions about clinical and legal risk management for clinicians trying keep patients safe and for patients with complex pregnancies trying to stay alive.
The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions.